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1. Introduction
As the burgeoning and ageing popula-
tion, an increasing number of patients 
are suffering from bone defects caused by 
physical trauma, tumor, and other bone 
diseases.[1] Therefore, bone tissue repair 
and regeneration have made consider-
able strides in the modern times. How-
ever, these problems are not adequately 
overcome by current remedies such as 
autografts, allografts, or synthetic bone 
graft substitutes.[2,3] Although autografts 
are still thought as “gold standard” for 
bone tissue repair, the major shortcom-
ings of autografts are the difficulties in 
the harvesting procedure, equivalently the 
donor site morbidity and the limited bone 
amount that can be collected.[4] What is 
more, allografts suffer from the difficult 
balance between immune rejection and 
immunosuppression and virus infection. 
To repair and regenerate bone tissue, the 
employment of stem cells and biomaterials is being investi-
gated and has become one of the best choices in bone tissue 
engineering.[5–8]
As an important cell type, mesenchymal stem cells (MSCs) 
have been used in tissue engineering.[9,10] MSCs have attracted 
much attention due to their unique capabilities of self-renewal 
in an undifferentiated state for prolonged time and multilineage 
differentiation after proper stimulation.[11] The differentiation 
and the fate of MSCs are known to be governed and regulated 
by a variety of biological and physiochemical cues in vivo.[12] 
To induce different lineage commitment, cells may require the 
appropriate extracellular signals to trigger or to promote this 
process. The biological growth factors have been widely dem-
onstrated to induce the differentiation of MSCs. For example, 
bone morphogenetic proteins (BMPs),[13] such as BMP-2 
and BMP-7, are known as the most potent growth factors for 
directing the osteogenesis of cells like MSCs and bone forma-
tion transforming growth factors (TGF-β1 and TGF-β3) can 
be utilized to enhance the direct differentiation of MSCs.[14,15] 
Additionally, many chemicals are frequently used in the specific 
osteogenic differentiation of cells in vitro. For instance, dexa-
methasone (DXM), ascorbic acid, and β-glycerophosphate are 
the typical osteogenic inducers for MSCs.[16]
Bioactive nanomaterials have attracted broad attention in 
bone tissue engineering studies due to their similarities to the 
Design and development of highly bioactive nanoscale biomaterials with 
enhanced osteogenic differentiation on adipose stem cells is rather important 
for bone regeneration and attracting much attention. Herein, monodispersed 
glycerophosphate-decorated bioactive glass nanoparticles (BGN@GP) are 
designed and their effect is investigated on the osteogenic differentiation 
of adipose mesenchymal stem cells (ADMSCs) and in vivo bone regenera-
tion. The surface-modified BGN@GP can be efficiently taken by ADMSCs 
and shows negligible cytotoxicity. The in vitro results reveal that BGN@GP 
significantly enhances the alkaline phosphatase activity and calcium biomine-
rialization of ADMSCs either under normal or osteoinductive medium as  
compared to BGNs. Further studies find that the osteogenic genes and 
proteins including Runx2 and Bsp in ADMSCs are significantly improved by 
BGN@GP even under normal culture medium. The in vivo animal experi-
ment confirms that BGN@GP significantly promotes the new bone formation 
in a rat skull defect model. This study suggests that bioactive small molecule 
decorating is an efficient strategy to improve the osteogenesis capacity of 
inorganic ceramics nanomaterials.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/ppsc.201900462.
Dr. Y. Guo, Dr. Y. Xue, Dr. J. Ge, Prof. B. Lei





Department of Biologic and Materials Sciences
University of Michigan
Ann Arbor, MI 48109, USA
Prof. B. Lei
National and Local Joint Engineering Research Center of Biodiagnosis 
and Biotherapy












Part. Part. Syst. Charact. 2020, 37, 1900462
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1900462 (2 of 10)
www.advancedsciencenews.com
www.particle-journal.com
nanostructured nature of extracellular microenvironment and 
native bone tissue.[17–20] Bioactive nanomaterials with special 
morphology and size have shown positive effect on the behavior 
of cells and biological molecules,[21,22] which is different from 
conventional bulk biomaterials.[23] For example, nanoscale 
bioactive ceramics biomaterials exhibited the enhanced oste-
ogenic differentiation on osteoblasts and stem cells.[24,25] 
Relative to other bioactive ceramics and polymers, bioactive 
glass-based biomaterials possess good biodegradation, bone-
bonding, osteogenesis and angiogenesis capacity,[8,26,27] due 
to their bioactive elements, and amorphous structure. Bioac-
tive glass materials for medical devices in dentistry and bone 
defect repair have been approved by Food and Drug Admin-
istration, suggesting their good safety and clinical effective-
ness.[28] Compared with traditional nanostructure bioactive 
particles, monodispersed nanoparticles could efficiently enter 
into the targeted cells and regulate the cell behavior through 
the action on the subcellular structure.[9,29,30] Previous studies 
have shown that monodispersed bioactive glass nanoparticles 
(BGNs) presented enhanced cell uptake and biodegradation, 
and improved biominerialization ability, demonstrated prom-
ising biomedical applications in bioimaging, gene delivery, bone 
regeneration, and wound healing.[10,21,25,27,30] Monodispersed 
BGNs and nanoscale silicon-based biomaterials could also effi-
ciently enhance the osteogenic differentiation of osteoblasts and 
bone marrow stem cells.[31–33] Recent years, our group further 
found that monodispersed BGNs could induce the osteogenic 
differentiation of adipose mesenchymal stem cells (ADMSCs) 
through activating the TGF-beta signaling pathway, and the 
molybdenum-based branched BGNs could also promote 
the osteogenic differentiation of ADMSCs.[34,35] However, the 
monodispersed BGNs without surface modification are easy to 
be aggregated during the using process. In addition, the further 
improvement on osteogenic activity of monodispersed BGNs in 
vitro and in vivo is still needed.
As an important element in the osteogenic differentiation 
system, β-glycerophosphate (GP) is often used in different bio-
materials scaffolds for bone tissue regeneration.[36] GP was also 
used to modify the physical and chemical property of biomate-
rials for cancer therapy.[37] In our previous study, it was shown 
that the abundant calcium components make BGN with great 
activity and exhibit strong affinity to different anions such as 
acetate and phosphate groups.[14] Our recent study also demon-
strated that GP could also stabilize the BGN through the strong 
interaction between Ca2+ in BGN and phosphate group in GP.[14] 
However, the effect of GP modification on the osteogenic dif-
ferentiation and bone regeneration of BGN is still not clear. 
Therefore, herein, we aim to investigate the interaction between 
BGN@GP and ADMSCs, and their effect on the osteogenic dif-
ferentiation of ADMSCs, as well as the in vivo bone regeneration.
2. Experimental Section
2.1. Preparation and Characterizations of BGN@GP 
Nanoparticle
The monodispersed BGNs were synthesized using the sol–gel-
template method, according to previous report.[27] BGN@GP 
nanoparticles were formed through the surface complex pro-
cess under mild condition (Scheme 1). Briefly, BGNs were first 
dispersed and sonicated in distilled (DI) water; GP was added 
to the BGNs solution and the mixture was sonicated again. The 
obtained mixture was separated by centrifugation and washed 
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Scheme 1. Monodispersed β-glycerophosphate-decorative bioactive glass nanoparticles improve osteogenic differentiation of adipose stem cells and 
bone tissue regeneration in vitro and in vivo.
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with DI water to remove the redundant GP. The final product 
of GP-modified BGNs was named as BGN@GP. The physico-
chemical structure of BGN@GP nanoparticles was character-
ized by the Fourier-transform infrared spectroscopy (FT-IR) 
spectra (Nicolet 6700, Thermo Scientific Instrument), transmis-
sion electron microscopy (TEM, H-8000, Hitachi), energy dis-
persive spectroscopy (EDS), field emission scanning electron 
microscope (SU8010, Hitachi). The detailed processes are avail-
able in Supporting Information.
2.2. Adipose Mesenchymal Stem Cells Culture and Cytotoxicity 
Evaluation
ADMSCs were obtained from American Type Culture Collection. 
The cells were cultured in (normal growth medium) Dulbecco’s 
Modified Eagle Medium (GIBCO) with 15% v/v fetal bovine 
serum (Invitrogen), 100 U mL−1 penicillin, and 100 mg mL−1 
streptomycin at 37 °C in humidified air containing 5% CO2. The 
ADMSCs were seeded onto plates with normal growth medium, 
and the medium was changed every two days. The osteoinduc-
tive medium was made up of normal growth medium, 10 nm 
DXM, 10 mm b-glycerophosphate, and 50 µg mL−1 l-ascorbic 
acid. The ADMSCs viability after incubation with BGN@GP 
with different concentrations (60–240 µg mL−1) for 5 days was 
evaluated through the Alamar blue assay (Invitrogen) and Live-
Dead staining kit (Invitrogen). The fluorescent intensity of mixed 
medium was measured at a 570/600 nm filter by a SpectraMax 
fluorescence microplate reader (Molecular Devices). At least five 
species per sample were tested. The cells were observed by an 
inverted fluorescence microscope (IX53, Olympus). The Sup-
porting Information shows the testing procedure.
2.3. Osteogenic Differentiation Assays of ADMSCs
The osteogenic differentiation of ADMSCs after culturing with 
BGN@GP at different concentrations (0–80 µg mL−1) was 
assessed by alkaline phosphatase (ALP) activity, calcium deposi-
tion analysis, osteogenic genes expressions, and osteogenic pro-
teins. The ALP activity was determined for early culture period 
marker and measured on the 3rd, 7th, and 14th day. The cel-
lular mineralization after cultivation for 3 weeks was evaluated 
by Alizarin Red S (ARS) kit (Genmed, Quebec). The expres-
sions of specific osteogenic genes including Runx2 and Bsp 
were measured by the quantitative real-time polymerase chain 
reaction (Applied Biosystems 7500). The primers are shown in 
Table S1, Supporting Information. The RUNX2 and BSP pro-
teins were evaluated using the immunofluoresencent staining 
based on the primary and secondary antibodies (Thermal). 
The detailed procedures for the osteogenic differentiation were 
similar with previous reports, as shown in the Supporting 
Information.
2.4. Animal Experiment and Bone Formation Evaluation In Vivo
The female Sprague Dawley (SD) mice used were maintained 
under standard animal housing conditions. SD mice were 
divided into two groups randomly. Animals were anaesthe-
tized with 2% inhalation of isoflurane. A trephine was used 
to create two 3 mm craniotomy defects on the calvarial bone, 
and the wounds were copiously irrigated with normal saline 
while drilling. The calvarial disk was removed carefully to avoid 
injury to the underlying dura or brain. BGN@GP nanoparti-
cles with F127 hydrogel were injectable into the bone defect, 
and the blank group was F127 hydrogel without nanoparticles. 
After 8 and 12 weeks, the calvarial bones were embedded in 
4% paraformaldehyde solution, and the region of the calvarial 
bone was scanned with micro-CT (Y.CHEETAH*, YXLON). For 
examination of new bone formation, the calvarias were fixed 
with 10% formalin, infiltrated by resin, and hard tissue slices 
were observed under light microscope after Hematoxylin-Eosin 
(H.E.) and Masson staining. The staining process of H.E and 
Masson can be seen in the Supporting Information.
2.5. Statistical Analysis
At least three independent experiments were executed and the 
data were represented as average values and standard devia-
tions (SDs). The Student-t test was used to determine the statis-
tical significance between two groups and the differences were 
considered as significant when *P < 0.05 or **P < 0.01.
3. Results and Discussion
3.1. Preparation and Characterizations of BGN@GP
The as-prepared BGN@GP were monodisperse and spherical in 
shape with the size of 300–400 nm (Figure 1A). EDS confirmed 
that the main elements of BGNs were Si and Ca. Comparing 
with BGNs, BGN@GP has more P element, suggesting the suc-
cessful modification by β-glycerophosphate (Figure 1B). What is 
more, the FT-IR spectrum indicated that the characteristic bands 
of SiOSi at 1000–1100 cm−1 and the typical peaks of PO 
at 550 and 950 cm−1(Figure 1C). The amorphous structure of 
BGN@GP was confirmed by the X-ray diffraction (XRD) analysis 
(Figure 1D). These results showed that the surface modification 
of GP did not affect the morphology, size, and structure of BGNs 
(Figure S1, Supporting Information). The calculated weight ratio 
of GP on BGN through the thermogravimetric analysis was 
about 3.2 wt%.
3.2. ADMSCs Cytotoxicity and Proliferation Analysis
In order to investigate the effect of BGN@GP on the growth 
of ADMSCs, the Alamar blue and live/dead staining assay 
were performed (Figure 2). It is obvious that most of the cells 
are alive (green), and few are dead (red), and all the ADMSCs 
exhibited a normal morphology after incubated with nanopar-
ticles at 60–240 µg mL−1 (Figure 2A). The cell viability was 
related to the concentration of BGN@GP, ADMSCs did not 
show any significant death after incubation with BGN@GP 
for 5 days at predetermined concentrations (0, 60, 120, and 
240 µg mL−1; Figure 2B). The high concentration of BGN@GP 
Part. Part. Syst. Charact. 2020, 37, 1900462
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nanoparticles (240 µg mL−1) exhibited some cytotoxicity, which 
was probably related with the high cell uptake in ADMSCs 
(Figure S2, Supporting Information). In addition, at the low 
concentration (60 µg mL−1), as compared with BGNs group, the 
BGN@GP group showed the similar cell viability and prolifera-
tion at the same concentration (Figure S3, Supporting Informa-
tion). Therefore, less than 100 µg mL−1 concentration was used 
in subsequent experiments. These results demonstrated that 
low concentration BGN@GP possessed good cellular biocom-
patibility and may be promising for further osteogenic differen-
tiation for ADMSCs.
3.3. Osteogenic Differentiation Investigations of ADMSCs
To demonstrate the effect of BGN@GP for osteogenic dif-
ferentiation of ADMSCs, ALP activity, mineralization, the 
expression of osteogenic marker genes and proteins were 
measured. ADMSCs were cultured with BGN@GP in normal 
and osteoinductive medium. First, ALP activity was detected 
as the early key event during the osteogenesis. As shown in 
Figure 3, on the 7th day, ALP activity achieved a peak under 
two culture conditions. Specially, the ALP activity of the 
20 µg mL−1 concentration groups were significantly stronger 
Part. Part. Syst. Charact. 2020, 37, 1900462
Figure 2. Cell viability and live cell imaging evaluation of BGN@GP, using the concentration of 0 µg mL−1 as a blank control. A) Live/dead staining fluo-
rescent images of ADMSCs after incubation with BGN@GP at different concentrations (0, 60, 120, and 240 µg mL−1, Scale bar = 200 µm). B) ADMSCs 
viability and proliferation after culture for 1, 3, and 5 days. *P < 0.05 and **P < 0.01.
Figure 1. Morphology and structure characterization of BGN@GP. A) TEM images, B) EDS spectra, C) FT-IR spectra, and D) XRD patterns.
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than the blank groups (Figure 3A). In the meantime, the same 
tendency occurred in osteoinductive medium groups, the ALP 
activity of the 20 µg mL−1 concentration BGN@GP groups were 
the highest among all groups (Figure 3B).Comparing with the 
same concentration of BGNs (20 µg mL−1), the ALP activity 
of BGN@GP groups were significantly enhanced than BGNs 
in both normal and osteoinductive groups (Figure S4, Sup-
porting Information). On the 14th day, ALP activity showed 
Part. Part. Syst. Charact. 2020, 37, 1900462
Figure 3. In vitro ALP activity evaluation of ADMSCs following induction by various concentration of BGN@GP in normal and osteoinductive medium. 
A) ALP activity analysis in normal growth medium. B) ALP activity in osteoinductive medium. The 0 µg mL−1 concentration group as control, *P < 0.05 
and **P < 0.01.
Figure 4. Calcium biomineralization evaluation of ADMSCs with different concentration of BGN@GP (0, 20, 50, and 80 µg mL−1) in vitro. A) Alizarin 
red staining assay at 21 days. B,C) Relative gray level analyzed by image J based on the alizarin red staining images. The concentration of 0 µg mL−1 
was regarded as a blank control. *P < 0.05 and **P < 0.01.
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no significant difference among these groups. These results 
indicated that the ALP activity of ADMSCs was significantly 
enhanced by the GP decorating on BGNs.
Calcium deposition was evaluated by ARS staining 
(Figure 4). Dark red area indicated the presence of calcium 
phosphate deposition in cellular matrix. After 21 days, the ARS 
staining photographs showed that BGN@GP groups had more 
obvious dark red areas than the blank groups, especially for 
the 80 µg mL−1 concentration BGN@GP groups (Figure 4A). 
The gray level analysis presented that the 80 µg mL−1 BGN@
GP groups showed higher calcium deposition (Figure 4B,C). 
In both normal and osteoinductive condition, the ARS relative 
intensity of BGN@GP groups was significantly improved than 
BGNs groups under the 80 µg mL−1 concentration (Figure S5, 
Supporting Information). These results indicated that BGN@
GP had a promotive effect on the mineralization of ADMSCs, 
even significantly stronger than the effect of BGNs.
In order to better understand the osteogenesis, the gene 
expression profile of the ADMSCs cultured with BGN@GP was 
performed (Figure 5). After 7 and 14 days, the relative Runx2 
(early-stage marker) expression of ADMSCs in 80 µg mL−1 
concentration BGN@GP groups was higher than the other 
groups (Figure 5A,B). For Bsp (late-stage marker) expression, 
the 50 and 80 µg mL−1 concentration of BGN@GP groups 
expressed similarly, which showed higher expression level than 
20 µg mL−1 BGN@GP groups and the blank groups under 
normal and osteoinduction conditions (Figure 5C,D). We also 
detected the Runx2 and Bsp expression of BGNs at 80 µg mL−1 
concentration. Comparing with BGN@GP, the expression level 
in BGNs group was significantly lower on the 14th day with dif-
ferent conditions (Figure S6, Supporting Information).
After cultured for 21 days, RUNX2 and BSP proteins 
expression were detected by immunofluorescent staining 
(Figure 6). For RUNX2 protein, the 80 µg mL−1 BGN@GP 
groups which had the strongest positive staining than other 
groups under osteoinductive medium. Among groups with 
normal medium, dispersive green fluorescence could be seen 
in 80 µg mL−1 BGN@GP groups, and less green staining 
could be seen in other concentration groups (Figure 6A). For 
BSP protein, only the 50 and 80 µg mL−1 BGN@GP groups 
had slightly green fluorescence in normal condition. However, 
under osteoinductive medium, the BSP protein expression 
was significantly enhanced. The green area and intensity of 50 
and 80 µg mL−1 BGN@GP groups were higher than the blank 
groups, and the green fluorescence of 20 µg mL−1 BGN@
GP groups was weakest (Figure 6B). Moreover, the images of 
immunofluorescent staining were used to gray level analysis 
by image J software. We found that the results of gray level 
analysis were consistent with immunofluorescent images 
results (Figure S7, Supporting Information). These data indi-
cated that BGN@GP can significantly improve osteogenic dif-
ferentiation in vitro.
Part. Part. Syst. Charact. 2020, 37, 1900462
Figure 5. Relative expression of bone-specific marker genes of ADMSCs cultured in normal and osteoinductive medium with different concentration 
of BGN@GP, during 7 and 14 days. A,B) The relative expression of Runx2 and Bsp with normal growth medium. C,D) The relative expression of Runx2 
and Bsp with osteoinductive medium. The expression of these genes was normalized against the housekeeping gene Gapdh and calculated by the 
ΔΔCT method. *P < 0.05 and **P < 0.01.
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3.4. Bone Formation Performance In Vivo
To evaluate the ability of BGN@GP nanoparticles in improving 
the reconstruction of calvarial bone defect in vivo, two 3 mm 
craniotomy defects were created in SD rats and BGNs/BGN@
GP-contained hydrogel was injected. After treated for 8 and 
12 weeks, the bone regeneration performance was evaluated 
by micro-CT and tissue staining. The analysis of micro-CT 
showed that more bone-like tissues were formed in the BGN 
and BGN@GP nanoparticles treated group at 8 and 12 weeks, 
compared with nanoparticles-free control (Figure 7A). Addi-
tionally, as compared to control and BGNs group, BGN@GP 
significantly enhanced the new bone formation either at 
8 or 12 W (Figure 7A). The calculated new bone regen-
eration ratio and trabecular thickness further confirmed 
the efficiency of BGN@GP nanoparticles in improving the 
bone regeneration (Figure 7B,C), and it was clearly found that 
the skull defects were nearly repaired completely at 12 weeks 
with BGN@GP. Subsequently, the histological examination 
was carried out to further evaluate the bone formation perfor-
mance. Comparing with blank groups, the H.E. staining indi-
cated that no obvious inflammation for BGNs and BGN@GP 
treated groups was found in the repaired area (Figure 8A). 
The Masson staining revealed the significantly increased col-
lagen deposition for BGN@GP group, compared with BGNs 
and blank group (Figure 8B). H.E. and Masson staining both 
Figure 6. Immunofluorescent staining of bone-specific protein RUNX2 and BSP in ADMSCs at day 21. RUNX2 (A) and BSP (B) proteins were colored 
green and nuclei were colored blue. Scale bar = 100 µm.
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showed more regenerated bone tissue formed in the defect 
area for the BGN@GP group. The results of animal experi-
ment suggested that BGN@GP could significantly enhance 
the bone regeneration as compared to conventional BGNs.
Monodispersed BGNs possess many special physicochemical 
and biological properties, however, conventional BGNs showed 
significant aggregation in physiological condition and low cell 
uptake and insufficient osteoinductive activity, which limit 
their wide application in injectable bone regeneration and drug 
delivery. Here, we demonstrated that the GP decorated BGNs 
(BGN@GP) showed excellent dispersibility and good cell uptake 
and enhanced osteogenic differentiation capacity. Compared 
with conventional BGNs, BGN@GP significantly enhanced 
the in vitro ALP activity, calcium biomineralization, osteogenic 
maker genes, and proteins expression of ADMSCs, as well as 
the in vivo bone formation. The enhanced osteogenic differ-
entiation of ADMSCs was probably attributed to the bioactive 
feature of BGNs and GP. Previous studies showed that mono-
dispersed BGNs could induce the osteogenic differentiation of 
ADMSCs through the signaling pathway of TGF-beta.[14,33] The 
main reasons of GP functionalization enhancing the osteogenic 
differentiation of BGN on ADMSCs could be shown as follows. 
First, GP modification significantly enhanced the degradation/
water-dispersion and the cell uptake of BGN (Figure S2, Sup-
porting Information), which would increase the intracellular 
ions concentration (ICP analysis) and improve the osteogenic 
differentiation.[38] Compared with BGN, the release concentra-
tion of Si, Ca, and P from BGN@GP significantly increased. 
Secondly, β-glycerophosphate plays an important role in classic 
osteogenic differentiation protocol for stem cells,[39] as a phos-
phate source for bone mineral.[40] In our study, the concentra-
tion of GP was increased for BGN@GP in normal (2.6 mm) 
and osteogenic differentiation medium (12.6 mm), which also 
contributed to the biomineralization and osteogenic differen-
tiation (Figure 4). Compared to other studies, the current work 
first demonstrated the effect of BGN@GP in promoting the 
osteogenic differentiation, calcium biomineralization, and bone 
regeneration in vivo. This study suggests that BGN@GP may 
act as promising biomaterials for bioimaging, drug delivery, 
and bone regenerative medicine.
4. Conclusion
In summary, the effect of BGN@GP nanoparticles on the 
osteogenic differentiation of ADMSCs and in vivo bone regen-
eration was clarified. BGN@GP showed low cytotoxicity on 
ADMSCs at low concentration which was similar with BGNs. 
As compared to BGNs, BGN@GP could significantly enhance 
the osteogenic differentiation of ADMSCs through stimu-
lating the ALP activity, calcium biomineralization, osteogenic 
genes (Runx2 and Bsp), and proteins expression (RUNX2 and 
BSP). The BGN@GP demonstrated better in vivo bone regen-
eration capacity compared with BGNs. This work provides a 
facile strategy of biomolecule modification on nanoparticles for 
enhancing their bone regeneration capacities.
Figure 7. In vivo bone regeneration evaluation. A) Micro-CT images of the bone defects at 8 and 12 weeks after implanting BGNs and BNG@GP. 
B) New bone formation ratio and C) trabecular thickness of BGN@GP, BGNs and blank groups. *P < 0.05 and **P < 0.01.
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Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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